MedTech News
VIVATRONIX and SpineX announce xStep device approval from CDSCO
The xStep device offers painless, non-invasive electrical stimulation to the spinal cord to treat paralysis.
Abbott gets FDA breakthrough nod for dual-energy ablation catheter
An Abbott (NYSE: ABT)+
official posted on social media to announce FDA breakthrough device designation for a new ablation catheter.
‘Smart insulin’ shows promise in reducing hypoglycemia bouts
Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a lab-designed protein, possibly opening the door to a new treatment avenue for people with type 1 diabetes.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice. Not only did up to 88% of the vaccinated mice remain tumor-free (depending on the cancer), but the vaccine reduced—and in some cases completely prevented—the cancer’s spread.
Abbott adds Laralab AI-based cardiac imaging tech
An Abbott (NYSE: ABT)+
official took to social media today to share that the company added Laralab to its portfolio of digital offerings.
Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval
ST. LOUIS, Oct. 9, 2025 /PRNewswire/ — Amplifi Vascular, developer of the first-of-its-kind Vein Dilation System designed to increase eligibility, improve creation and early maturation of arteriovenous fistulas (AVFs) for hemodialysis, today announced three major milestones: positive first-in-human (FIH) study results, the close of a $6.9 million Series A financing, and U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE).
System can detect genetic mutations in brain tumors during surgery in just 25 minutes
A research team in Japan has developed an innovative system that can accurately detect genetic mutations in brain tumors within just 25 minutes. Genetic mutations are crucial markers for diagnosis of brain tumors.
Portable sensor detects synthetic cannabinoids in e-cigarettes and biological fluids
Even though electronic cigarettes do not contain any illicit substances, the liquid can cause serious health problems. Often, the nicotine concentration in these products is several times higher than in conventional cigarettes, promoting rapid addiction.